dOptimal lipid storage and mobilization are essential for efficient adipose tissue. Nuclear receptor peroxisome proliferator-activated receptor ␥ (PPAR␥) regulates adipocyte differentiation and lipid deposition, but its role in lipolysis and dysregulation in obesity is not well defined. This investigation aimed to understand the molecular impact of dysfunctional PPAR␥ on the lipolytic axis and to explore whether these defects are also confirmed in common forms of human obesity. For this purpose, we used the P465L PPAR␥ mouse as a model of dysfunctional PPAR␥ that recapitulates the human ppar␥ mutation (P467L). We demonstrated that defective PPAR␥ impairs catecholamine-induced lipolysis. This abnormal lipolytic response is exacerbated by a state of positive energy balance in leptin-deficient ob/ob mice. We identified the protein kinase A (PKA) network as a PPAR␥-dependent regulatory node of the lipolytic response. Specifically, defective PPAR␥ is associated with decreased basal expression of prkaca (PKAcat␣) and d-akap1, the lipase genes Pnplaz (ATGL) and Lipe (HSL), and lipid droplet protein genes fsp27 and adrp in vivo and in vitro. Our data indicate that PPAR␥ is required for activation of the lipolytic regulatory network, dysregulation of which is an important feature of obesity-induced insulin resistance in humans. P eroxisome proliferator-activated receptor ␥ (PPAR␥) is an important regulator of adipogenesis and lipogenesis. However, accumulating evidence suggests that PPAR␥ may also coordinate the balance between fat deposition and mobilization through its effects on lipolysis. To elucidate the relevance of PPAR␥ for the lipolytic response, we took advantage of a rare ppar␥ mutation that causes lipodystrophy and severe metabolic disturbances in humans (34). According to the crystal structure, the P467L PPAR␥ mutation is situated in helix 12, an important region for ligand binding and PPAR transactivation (4). Characterization of patients with genetic defects in ppar␥ has revealed metabolic inflexibility in their adipose tissue, resulting from impaired fat sequestration to lipid droplets (LDs) and decreased nonesterified fatty acid mobilization (34, 37). However, the dissection of the PPAR␥-dependent mechanisms that impair the flux of lipids in and out of adipose tissue has proven difficult, given the small number of patients affected by these mutations. In this respect, a humanized mouse model harboring a homologous mutation (P465L) offers clear experimental advantages.Initial analysis of the humanized P465L PPAR␥ mice revealed that, unlike humans, these mice exhibited normal amounts of adipose tissue and were unexpectedly insulin sensitive (13). This apparent paradox was partially resolved when the P465L PPAR␥ mouse was crossed onto an ob/ob background. Under this condition of extreme positive energy balance, the P465L PPAR␥ mutant mouse recapitulated the human phenotype characterized by insulin resistance, reduced fat mass, hypertension, and dyslipidemia. In fact, the same deleterious, synergistic dysmet...